Tomoko Maeda‐Chubachi

918 total citations
25 papers, 646 citations indexed

About

Tomoko Maeda‐Chubachi is a scholar working on Dermatology, Virology and Epidemiology. According to data from OpenAlex, Tomoko Maeda‐Chubachi has authored 25 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Dermatology, 9 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Tomoko Maeda‐Chubachi's work include Dermatology and Skin Diseases (9 papers), Poxvirus research and outbreaks (9 papers) and Psoriasis: Treatment and Pathogenesis (6 papers). Tomoko Maeda‐Chubachi is often cited by papers focused on Dermatology and Skin Diseases (9 papers), Poxvirus research and outbreaks (9 papers) and Psoriasis: Treatment and Pathogenesis (6 papers). Tomoko Maeda‐Chubachi collaborates with scholars based in United States, United Kingdom and Canada. Tomoko Maeda‐Chubachi's co-authors include Emily Edson‐Heredia, Kelly Gallagher, John E. Kraus, K. Thomas Robbins, Baojin Zhu, Amy S. Paller, Sterling Wu, Jiaying Guo, Robert Bissonnette and Alexa B. Kimball and has published in prestigious journals such as SHILAP Revista de lepidopterología, Ophthalmology and Journal of Investigative Dermatology.

In The Last Decade

Tomoko Maeda‐Chubachi

25 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoko Maeda‐Chubachi United States 14 331 321 117 108 98 25 646
N Sönnichsen Germany 11 286 0.9× 182 0.6× 98 0.8× 81 0.8× 32 0.3× 107 598
Margaret Song South Korea 15 336 1.0× 174 0.5× 48 0.4× 71 0.7× 49 0.5× 46 574
Steven E. Prawer United States 14 406 1.2× 197 0.6× 84 0.7× 74 0.7× 51 0.5× 23 825
S. Erdmann Germany 15 409 1.2× 149 0.5× 363 3.1× 90 0.8× 103 1.1× 39 703
Ines Brajac Croatia 18 358 1.1× 214 0.7× 23 0.2× 55 0.5× 62 0.6× 53 859
Jørgen Esmann Denmark 11 208 0.6× 133 0.4× 51 0.4× 13 0.1× 19 0.2× 19 587
Abdullateef A. Alzolibani Saudi Arabia 21 435 1.3× 185 0.6× 73 0.6× 122 1.1× 72 0.7× 57 976
Ahmad A. Al Robaee Saudi Arabia 18 344 1.0× 149 0.5× 60 0.5× 82 0.8× 67 0.7× 44 696
Muhterem Polat Türkiye 12 235 0.7× 75 0.2× 45 0.4× 49 0.5× 19 0.2× 40 420
Enayat Attwa Egypt 11 126 0.4× 128 0.4× 12 0.1× 37 0.3× 15 0.2× 23 352

Countries citing papers authored by Tomoko Maeda‐Chubachi

Since Specialization
Citations

This map shows the geographic impact of Tomoko Maeda‐Chubachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Maeda‐Chubachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Maeda‐Chubachi more than expected).

Fields of papers citing papers by Tomoko Maeda‐Chubachi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Maeda‐Chubachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Maeda‐Chubachi. The network helps show where Tomoko Maeda‐Chubachi may publish in the future.

Co-authorship network of co-authors of Tomoko Maeda‐Chubachi

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Maeda‐Chubachi. A scholar is included among the top collaborators of Tomoko Maeda‐Chubachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Maeda‐Chubachi. Tomoko Maeda‐Chubachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paller, Amy S., et al.. (2024). Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis. Pediatric Dermatology. 41(3). 438–444. 1 indexed citations
2.
Sugarman, Jeremy, Adelaide A. Hebert, John Browning, et al.. (2023). Berdazimer gel for molluscum contagiosum: An integrated analysis of 3 randomized controlled trials. Journal of the American Academy of Dermatology. 90(2). 299–308. 8 indexed citations
3.
Ward, Brian M., Daniel A. Riccio, Martina Cartwright, & Tomoko Maeda‐Chubachi. (2023). The Antiviral Effect of Berdazimer Sodium on Molluscum Contagiosum Virus Using a Novel In Vitro Methodology. Viruses. 15(12). 2360–2360. 6 indexed citations
4.
5.
Maeda‐Chubachi, Tomoko, David Hébert, Elizabeth K. Messersmith, & Elaine C. Siegfried. (2021). SB206, a Nitric Oxide–Releasing Topical Medication, Induces the Beginning of the End Sign and Molluscum Clearance. SHILAP Revista de lepidopterología. 1(3). 100019–100019. 16 indexed citations
6.
Riccio, Daniel A., et al.. (2020). Nitric oxide as a topical treatment for cervical intraepithelial neoplasia caused by high-risk human papillomavirus infection. Medical Research Archives. 8(6). 1 indexed citations
7.
Guttman‐Yassky, Emma, Ana B. Pavel, Todd A. Durham, & Tomoko Maeda‐Chubachi. (2019). 586 Topical nitric oxide releasing therapy with 2% SB414 cream downregulated major gene expressions in patients with atopic dermatitis. Journal of Investigative Dermatology. 139(5). S101–S101. 2 indexed citations
8.
Maeda‐Chubachi, Tomoko, et al.. (2019). LB1096 Results of phase 2 study evaluating the efficacy and safety of SB206, topical berdazimer sodium gel, in subjects with Molluscum Contagiosum. Journal of Investigative Dermatology. 139(9). B14–B14. 1 indexed citations
9.
Hebert, Adelaide A., et al.. (2019). Efficacy and tolerability of an investigational nitric oxide–releasing topical gel in patients with molluscum contagiosum: A randomized clinical trial. Journal of the American Academy of Dermatology. 82(4). 887–894. 28 indexed citations
10.
Tyring, Stephen K., Theodore Rosen, Brian Berman, et al.. (2018). A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment.. Journal of Drugs in Dermatology. 17(10). 1100–1105. 16 indexed citations
11.
Paller, Amy S., Tomoko Maeda‐Chubachi, Sterling Wu, et al.. (2018). A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis. Journal of the American Academy of Dermatology. 80(1). 89–98.e3. 129 indexed citations
12.
Elewski, Boni E., et al.. (2018). A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea Pedis.. PubMed. 17(8). 888–893. 4 indexed citations
13.
Bissonnette, Robert, et al.. (2018). Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study. Clinical Pharmacology in Drug Development. 7(5). 524–531. 30 indexed citations
14.
Kimball, Alexa B., Emily Edson‐Heredia, Baojin Zhu, et al.. (2016). Understanding the Relationship Between Pruritus Severity and Work Productivity in Patients With Moderate-to-Severe Psoriasis: Sleep Problems Are a Mediating Factor.. PubMed. 15(2). 183–8. 21 indexed citations
15.
Kuligowski, Michael E., et al.. (2016). 543 An evaluator blinded study to evaluate the cumulative irritation potential of topically-applied GSK2894512 cream in healthy subjects. Journal of Investigative Dermatology. 136(5). S96–S96. 1 indexed citations
16.
Edson‐Heredia, Emily, Baojin Zhu, C. Lefèvre, et al.. (2014). Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink. Journal of the European Academy of Dermatology and Venereology. 29(5). 955–963. 81 indexed citations
17.
Maeda‐Chubachi, Tomoko, Brad D. Simons, Dominique Brémond‐Gignac, et al.. (2013). Impact of Age, Diagnosis, and History of Glaucoma Surgery on Outcomes in Pediatric Patients Treated With Latanoprost. Journal of Glaucoma. 22(8). 614–619. 9 indexed citations
18.
Edson‐Heredia, Emily, K.L. Sterling, Carlos Alatorre, et al.. (2013). Heterogeneity of Response to Biologic Treatment: Perspective for Psoriasis. Journal of Investigative Dermatology. 134(1). 18–23. 67 indexed citations
19.
Raber, Susan, Rachel Courtney, Tomoko Maeda‐Chubachi, et al.. (2011). Latanoprost Systemic Exposure in Pediatric and Adult Patients with Glaucoma: A Phase 1, Open-Label Study. Ophthalmology. 118(10). 2022–2027. 18 indexed citations
20.
Maeda‐Chubachi, Tomoko, et al.. (2011). Comparison of Latanoprost and Timolol in Pediatric Glaucoma: A Phase 3, 12-Week, Randomized, Double-Masked Multicenter Study. Ophthalmology. 118(10). 2014–2021. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N Sönnichsen Breakdown of academic impact, for papers by Margaret Song Breakdown of academic impact, for papers by Steven E. Prawer Breakdown of academic impact, for papers by S. Erdmann Breakdown of academic impact, for papers by Ines Brajac Breakdown of academic impact, for papers by Jørgen Esmann Breakdown of academic impact, for papers by Abdullateef A. Alzolibani Breakdown of academic impact, for papers by Ahmad A. Al Robaee Breakdown of academic impact, for papers by Muhterem Polat Breakdown of academic impact, for papers by Enayat Attwa
Rankless by CCL
2026